An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection-Reference-Cited by-同舟云学术

An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection

Published:2016-12-22 Issue:12 Volume:11 Page:e0163089
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lambkin-Williams Rob^ORCID,Gelder Colin,Broughton Richard,Mallett Corey P.,Gilbert Anthony S.,Mann Alex,He David,Oxford John S.,Burt David

Funder

ID Biomedical

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2016–17 influenza season;LA Grohskopf;MMWR Recomm Rep,2016

2. New approaches to influenza chemotherapy. Neuraminidase inhibitors;DP Calfee;Drugs,1998

3. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection;DP Calfee;Antivir Ther,1999

4. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment;L Barroso;Antivir Ther,2005

5. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza;FG Hayden;JAMA,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy;The Lancet Infectious Diseases;2023-12

2. Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2;Nature Communications;2023-07-29

3. Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system;Statistics in Medicine;2023-02-15

4. Controlled Human Infection Models To Accelerate Vaccine Development;Clinical Microbiology Reviews;2022-09-21

5. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients;Viruses;2022-09-18